Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancy

[1]  Emmanuel C. Alozie,et al.  Promises and Challenges , 2015 .

[2]  T. Reimer,et al.  miRNA expression profiles determined in maternal sera of patients with HELLP syndrome , 2014, Hypertension in pregnancy.

[3]  J. Carles,et al.  Identification of Tissue microRNAs Predictive of Sunitinib Activity in Patients with Metastatic Renal Cell Carcinoma , 2014, PloS one.

[4]  V. Novotna,et al.  Circulating C19MC MicroRNAs in Preeclampsia, Gestational Hypertension, and Fetal Growth Restriction , 2013, Mediators of inflammation.

[5]  Anthony O. Olarerin-George,et al.  miR-210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia. , 2013, The American journal of pathology.

[6]  Zuhong Lu,et al.  Maternal Plasma miRNAs Expression in Preeclamptic Pregnancies , 2013, BioMed research international.

[7]  Ping Huang,et al.  MicroRNA-143 inhibits cell migration and invasion by targeting matrix metalloproteinase 13 in prostate cancer. , 2013, Molecular medicine reports.

[8]  H. Figueroa-Diesel,et al.  First trimester prediction of early onset preeclampsia using demographic, clinical, and sonographic data: a cohort study , 2013, Prenatal diagnosis.

[9]  S. Juo,et al.  Decreased MicroRNA-221 is Associated with High Levels of TNF-α in Human Adipose Tissue-Derived Mesenchymal Stem Cells From Obese Woman , 2013, Cellular Physiology and Biochemistry.

[10]  Qing Xu,et al.  Repression of miR-143 mediates Cr (VI)-induced tumor angiogenesis via IGF-IR/IRS1/ERK/IL-8 pathway. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  R. Robitaille,et al.  Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges. , 2013, Clinical biochemistry.

[12]  Zhihong Yang,et al.  A Feedback Inhibition between miRNA-127 and TGFβ/c-Jun Cascade in HCC Cell Migration via MMP13 , 2013, PloS one.

[13]  Hong Zhang,et al.  MTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b , 2013, Journal of experimental & clinical cancer research : CR.

[14]  R. Rodrigo,et al.  Prediction of early and late pre‐eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[15]  G. Fu,et al.  MicroRNAs in Human Placental Development and Pregnancy Complications , 2013, International journal of molecular sciences.

[16]  E. Gratacós,et al.  Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting. , 2013, American journal of obstetrics and gynecology.

[17]  Qing Xu,et al.  Roles and Mechanism of miR-199a and miR-125b in Tumor Angiogenesis , 2013, PloS one.

[18]  D. Amadori,et al.  miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis , 2013, Nature Cell Biology.

[19]  Yan Zhang,et al.  Inflammatory Markers and Risk of Type 2 Diabetes , 2012, Diabetes Care.

[20]  L. Boulet,et al.  Decreased miR-192 expression in peripheral blood of asthmatic individuals undergoing an allergen inhalation challenge , 2012, BMC Genomics.

[21]  K. Stamatakis,et al.  miR-127 Protects Proximal Tubule Cells against Ischemia/Reperfusion: Identification of Kinesin Family Member 3B as miR-127 Target , 2012, PloS one.

[22]  F. Rousseau,et al.  Candidate biochemical markers for screening of pre-eclampsia in early pregnancy , 2012, Clinical chemistry and laboratory medicine.

[23]  Lin Feng,et al.  Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta. , 2012, The Journal of clinical endocrinology and metabolism.

[24]  S. Roberge,et al.  Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis , 2012, Fetal Diagnosis and Therapy.

[25]  X. Chen,et al.  Secreted microRNAs: a new form of intercellular communication. , 2012, Trends in cell biology.

[26]  Hai-yan Lin,et al.  Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies. , 2012, Reproduction.

[27]  Qingguo Wang,et al.  MicroRNA-127 Inhibits Lung Inflammation by Targeting IgG Fcγ Receptor I , 2012, The Journal of Immunology.

[28]  N. Vitoratos,et al.  Molecular Mechanisms of Preeclampsia , 2012, Journal of pregnancy.

[29]  X. Chen,et al.  Horizontal transfer of microRNAs: molecular mechanisms and clinical applications , 2012, Protein & Cell.

[30]  Zuhong Lu,et al.  Application of next-generation sequencing technology to profile the circulating microRNAs in the serum of preeclampsia versus normal pregnant women. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[31]  P. Akçakaya,et al.  Serum microRNA expression in pregnancies with preeclampsia. , 2011, Genetics and molecular research : GMR.

[32]  C. Fernández-Hernando,et al.  Smooth Muscle miRNAs Are Critical for Post-Natal Regulation of Blood Pressure and Vascular Function , 2011, PloS one.

[33]  E. Kroh,et al.  Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.

[34]  D. Enquobahrie,et al.  Placental microRNA expression in pregnancies complicated by preeclampsia. , 2011, American journal of obstetrics and gynecology.

[35]  K. Vickers,et al.  MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins , 2011, Nature Cell Biology.

[36]  Argyro Syngelaki,et al.  Prediction of early, intermediate and late pre‐eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks , 2011, Prenatal diagnosis.

[37]  P. Schubert,et al.  Are Early and Late Preeclampsia Distinct Subclasses of the Disease—What Does the Placenta Reveal? , 2010, Hypertension in pregnancy.

[38]  François Audibert,et al.  Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy: A Meta-Analysis , 2010, Obstetrics and gynecology.

[39]  Andrew Williams,et al.  Cross-platform analysis of global microRNA expression technologies , 2010, BMC Genomics.

[40]  Y. Matsuki,et al.  Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells*♦ , 2010, The Journal of Biological Chemistry.

[41]  Junli Zhao,et al.  Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia , 2009, Clinical chemistry and laboratory medicine.

[42]  M. Dimatteo,et al.  Physician Communication and Patient Adherence to Treatment: A Meta-Analysis , 2009, Medical care.

[43]  T. Han,et al.  Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. , 2009, American journal of obstetrics and gynecology.

[44]  Gozoh Tsujimoto,et al.  Intra-Platform Repeatability and Inter-Platform Comparability of MicroRNA Microarray Technology , 2009, PloS one.

[45]  G. Novelli,et al.  Early and Late Preeclampsia: Two Different Maternal Hemodynamic States in the Latent Phase of the Disease , 2008, Hypertension.

[46]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[47]  Stefanie Dimmeler,et al.  Role of microRNAs in vascular diseases, inflammation, and angiogenesis. , 2008, Cardiovascular research.

[48]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[49]  Chunxiang Zhang.  MicroRNomics: a newly emerging approach for disease biology. , 2008, Physiological genomics.

[50]  E. Gratacós,et al.  Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. , 2006, American journal of obstetrics and gynecology.

[51]  K. Livak,et al.  Real-time quantification of microRNAs by stem–loop RT–PCR , 2005, Nucleic acids research.

[52]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[53]  Jm Roberts,et al.  Pathogenesis and genetics of pre-eclampsia , 2001, The Lancet.

[54]  Jean-Marie Moutquin,et al.  The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) , 2001, Hypertension in pregnancy.

[55]  James J. Walker,et al.  Pre-eclampsia , 2000, The Lancet.

[56]  J. Fleming,et al.  A CRITICAL EVALUATION OF SONAR “CROWN‐RUMP LENGTH” MEASUREMENTS , 1975, British journal of obstetrics and gynaecology.

[57]  Caifu Chen,et al.  Stem-loop RT-qPCR for microRNA expression profiling. , 2012, Methods in molecular biology.

[58]  R. Hellens,et al.  Quantitative stem-loop RT-PCR for detection of microRNAs. , 2011, Methods in molecular biology.

[59]  J. Hurley,et al.  miRNA profiling on high-throughput OpenArray™ system. , 2011, Methods in molecular biology.

[60]  X. H. Liu,et al.  Genet. Mol. Res. , 2011 .

[61]  A. MacLullich,et al.  a systematic review and meta-analysis , 2011 .

[62]  BMC Genomics BioMed Central Methodology article Reproducibility of quantitative RT-PCR array in miRNA , 2009 .

[63]  J Figueras,et al.  Customized birthweight standards for a Spanish population. , 2008, European journal of obstetrics, gynecology, and reproductive biology.

[64]  S. Drăghici,et al.  BASIC SCIENCE: OBSTETRICS , 2022 .